Trials / Not Yet Recruiting
Not Yet RecruitingNCT06077071
MRIdian "RADAR" Trial
MRIdian "RADAR" Trial - Radiosurgical Debulking of Asymptomatic/Radiographic Spinal Cord Compression Using Stereotactic MRI-guided Adaptive Radiotherapy
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to see if treating cancer with the magnetic resonance imaging guided adaptive radiotherapy (MRIdian) can control patient's tumor and eliminate the need for surgery used to treat nerves in the spine flattened by pressure (compressed).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | ViewRay MRIdian Stereotactic Radiosurgery | Participants will undergo stereotactic radiosurgery of the spinal cord on the ViewRay MRIdian, a hybrid MRI-linac platform, with 40 Gy in 5 fractions prescribed to the planning target volume (PTV). |
Timeline
- Start date
- 2026-07-01
- Primary completion
- 2030-07-01
- Completion
- 2030-07-01
- First posted
- 2023-10-11
- Last updated
- 2026-04-01
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06077071. Inclusion in this directory is not an endorsement.